AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

First Observatory of Precocious Puberty.

Recruitingn/aAges any - 11 YearsAllHospices Civils de Lyon
💬

In plain words

What the trial is, and whether it could suit you

The age of puberty has fluctuated throughout history. Recent data shows an increase in the age of onset of puberty signs, in the United States but also in Europe. A recent Public Health France study published in 2018 reports an increase in the incidence of precocious puberty with geographical heterogeneity. The consequences of these appearances include the early onset of menarche, short adult height and the psychological impact. Due to a lack of studies and additional data, the reasons for this development are difficult to understand. Among current hypotheses, the entanglement with the evolution of our environment is at the forefront: the action of environmental endocrine disruptors and nutritional factors could play a role in the process of early appearance of pubertal signs. The establishment of a national observatory for early and advanced puberty in collaboration with pediatric end

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: Precocious puberty group (PP) : * Suspected precocious puberty (girl aged \< 8 years or boy aged \< 9 years when the first signs of development\* appear) * Suspected precocious puberty (girl aged \< 8 years or boy aged \< 9 years when the first signs of development\* appear) Advanced puberty group (AP) : * Suspected advanced puberty (girl aged ≥ 8 and \< 10 years or boy aged ≥ 9 and \< 11 years when the first signs of development\* appear) * First consultation with the investigator (pediatric endocrinologist). Control group : * Boy or girl without signs of pubertal development (Tanner 1); * Matched to the PP group on sex and age (+/- 1 year); * Consultation with the same investigator over the same period (same quarter) as a patient in the PP group Exclusion Criteria: All groups * Consultation with the same investigator over the same period (same quarter) as a patient in the PP group * Family not speaking French, language barrier.
💊

What it tests

  • Not listed
📍

Where

25 sites
Clinique du Val d'Ouest
Écully, France
Clinique du Val d'Ouest
Écully, France
Clinique du Val d'Ouest
Écully, France
Pediatric practice
Lyon, France
Pediatric practice
Rennes, France
Pediatric practice
Chambray-lès-Tours, France
Pediatric practice
Essey-lès-Nancy, France
Pediatric practice
Levallois-Perret, France

…and 17 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy